Arbutus Biopharma Reacquires Rights to Imdusiran in Greater China, Concludes Partnership with Qilu Pharmaceutical
25/6 13:41
Arbutus reclaims rights to imdusiran in Greater China and establishes a new Scientific Advisory Board for chronic HBV treatment....